Afficher la couverture 'Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications | Jézéquel, Pascal' en grand format
/5

0 avis

Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

Archive ouverte

Jézéquel, Pascal | Kerdraon, Olivier | Hondermarck, Hubert | Guérin-Charbonnel, Catherine | Lasla, Hamza | Gouraud, Wilfried | Canon, Jean-Luc | Gombos, Andrea | Dalenc, Florence | Delaloge, Suzette | Lemonnier, Jérôme | Loussouarn, Delphine | Verriele, Veronique | Campone, Mario

Edité par CCSD ; BioMed Central -

International audience. BACKGROUND:Heterogeneity and lack of targeted therapies represent the two main impediments to precision treatment of triple-negative breast cancer (TNBC), and therefore, molecular subtyping and identification of therapeutic pathways are required to optimize medical care. The aim of the present study was to define robust TNBC subtypes with clinical relevance.METHODS:Gene expression profiling by means of DNA chips was conducted in an internal TNBC cohort composed of 238 patients. In addition, external data (n = 257), obtained by using the same DNA chip, were used for validation. Fuzzy clustering was followed by functional annotation of the clusters. Immunohistochemistry was used to confirm transcriptomics results: CD138 and CD20 were used to test for plasma cell and B lymphocyte infiltrations, respectively; MECA79 and CD31 for tertiary lymphoid structures; and UCHL1/PGP9.5 and S100 for neurogenesis.RESULTS:We identified three molecular clusters within TNBC: one molecular apocrine (C1) and two basal-like-enriched (C2 and C3). C2 presented pro-tumorigenic immune response (immune suppressive), high neurogenesis (nerve infiltration), and high biological aggressiveness. In contrast, C3 exhibited adaptive immune response associated with complete B cell differentiation that occurs in tertiary lymphoid structures, and immune checkpoint upregulation. External cohort subtyping by means of the same approach proved the robustness of these results. Furthermore, plasma cell and B lymphocyte infiltrates, tertiary lymphoid structures, and neurogenesis were validated at the protein levels by means of histological evaluation and immunohistochemistry.CONCLUSION:Our work showed that TNBC can be subcategorized in three different subtypes characterized by marked biological features, some of which could be targeted by specific therapies.

Suggestions

Du même auteur

Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response

Archive ouverte | Jézéquel, Pascal | CCSD

International audience. INTRODUCTION: Triple-negative breast cancers need to be refined in order to identify therapeutic subgroups of patients.METHODS: We conducted an unsupervised analysis of microarray gene-expres...

iTRAQ‐Based Quantitative Proteomic Analysis Strengthens Transcriptomic Subtyping of Triple‐Negative Breast Cancer Tumors

Archive ouverte | Jézéquel, Pascal | CCSD

International audience. Heterogeneity and lack of targeted therapies represent the two main impediments to precision treatment of triple-negative breast cancer (TNBC). Therefore, molecular subtyping and identificati...

Development of an absolute assignment predictor for triple-negative breast cancer subtyping using machine learning approaches

Archive ouverte | Ben Azzouz, Fadoua | CCSD

International audience. Triple-negative breast cancer (TNBC) heterogeneity represents one of the main obstacles to precision medicine for this disease. Recent concordant transcriptomics studies have shown that TNBC ...

Chargement des enrichissements...